Related Experiment Video
Updated: Nov 25, 2025

07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.5K
Recent Developments in Pathological pH-Responsive Polymeric Nanobiosensors for Cancer Theranostics
E K Pramod Kumar1, Wooram Um1, Jae Hyung Park1,2
1School of Chemical Engineering, College of Engineering, Sungkyunkwan University, Suwon, South Korea.
Frontiers in Bioengineering and Biotechnology
|December 17, 2020
Summary
pH-responsive theranostic polymeric nanobiosensors (TPNBS) offer advanced cancer detection and treatment. These nanobiosensors leverage tumor acidity for targeted delivery and enhanced therapeutic efficacy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Polymeric nanobiosensors (PNBS) show promise for disease detection due to their sensitivity and specificity to tumor-related factors like pH.
- These sensors can be transformed into theranostic polymeric nanobiosensors (TPNBS) by integrating therapeutic agents for combined diagnosis and treatment.
- The polymeric components are crucial for enhancing stability, biocompatibility, and targeted accumulation of TPNBS at pathological sites.
Purpose of the Study:
- To review recent advancements in the design, preparation, and characterization of pH-responsive TPNBS.
- To explore the potential of these TPNBS as effective in vivo nanotheranostic agents within acidic tumor microenvironments.
Main Methods:
- Summarizing recent developments in the field of pH-responsive TPNBS.
- Characterizing the design and preparation of these nanobiosensors.
- Evaluating their performance as in vivo nanotheranostic agents.
Main Results:
- pH sensitivity of TPNBS facilitates tumor-specific accumulation, improved tumor penetration, and enhanced cellular uptake.
- This pH responsiveness enables theranostic activation, leading to improved bioimaging signals and controlled therapeutic agent release.
- TPNBS demonstrate significant potential for efficient in vivo nanotheranostics in acidic cancer environments.
Conclusions:
- pH-responsive TPNBS are highly effective nanocarriers for cancer theranostics.
- Their design and properties are optimized for the acidic tumor microenvironment, improving therapeutic outcomes.
- Further development of TPNBS holds promise for advanced cancer diagnosis and treatment strategies.

